Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative inactivated Pseudomonas aeruginosa injection for enhanced postoperative recovery after thyroid cancer central lymph node dissection
ChiCTR2000034086Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of PA-MSHA in thyroid cancer (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Postoperative length of stay, Total medical costs and 5 more. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
PA-MSHA
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on ChiCTR2000034086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034086.